WUHAN GENERAL GROUP INC - WUHN STOCK NEWS

Wuhan General Group, Inc. (WUHN) has launched a new line of CBD Muscle and Joint Rubs endorsed by MMA fighter Rob Simbowe. The product line, featuring three variants, aims to provide pain relief, pre-workout warming, and post-workout cooling effects. These products will first be available in South Africa and Zambia, utilizing high-quality CBD and African medicinal ingredients. The company emphasizes the importance of Simbowe's role as a brand ambassador, highlighting his commitment to fitness and health. WUHN also focuses on raising awareness of alternative plant-based therapies.

Wuhan General Group (OTC PINK: WUHN) announced that its brands Medspresso and Liviana are now available in over 100 independent retailers in the Cape Town region. The company has seen substantial growth in stockists since their launch in late 2021, with a focus on quality products and service. CEO Jeff Robinson highlighted a goal of expanding to 600 stores by year-end. The company emphasizes educating consumers about the benefits of CBD through premium food and beverages. Currently, they offer 14 SKUs, aiming for 42 by the end of 2022.

Wuhan General Group, Inc. (OTC PINK: WUHN) announced its participation in the Master Investor Show on March 19, 2022, in London, UK. CEO Jeff Robinson and CMO Dr. Anna Morera Leralta will engage with around 5000 attendees, focusing on investment opportunities in biotechnology and related fields. The show aims to foster networking and provide insights from industry experts. The company continues to advance its commitment to plant-based cannabinoids and mental health research through its subsidiary, MJ MedTech.

Wuhan General Group, Inc. (WUHN) has announced the launch of Ketamine IV and Supercharged Vitamin IV Therapy at its M2Bio Labs in Cape Town. These therapies aim to enhance physical and mental well-being with 100% bioavailability, using customized intravenous vitamin drips. The drips can significantly benefit energy levels, immune support, and mental clarity. Additionally, the facility will offer Ketamine Assisted Psychotherapy for various mental health conditions.

Wuhan General Group, Inc. (WUHN) has announced that its subsidiary, Medspresso, is now a member of the Speciality Coffee Association of South Africa (SCASA). This membership aims to enhance Medspresso's commitment to quality in the coffee industry, with a focus on high-quality products and industry cooperation. The company's mission includes advancing plant-based medicine, particularly through cannabinoid and psilocybin research for mental health.

Wuhan General Group, Inc. (OTC: WUHN) announced the launch of Medspresso's new single-serve Super Booster Functional Mushroom Sachets and Active CBD Sachets. These products meet high food standards and contain no harmful additives. Each CBD sachet includes 20 mg of pharmaceutical-grade CBD isolate, which is double the typical market offering. The sachets are designed for convenience, being water-soluble and suitable for any beverage. This launch is part of the company's ongoing initiative to diversify its product line, aiming to capitalize on the growing demand for health supplements.

Wuhan General Group, Inc. (OTC PINK:WUHN) has announced the launch of Neurai Life Sciences, a biotechnology company focused on developing therapies for mental health disorders. Neurai will utilize artificial intelligence for drug discovery and aims to address issues such as major depressive disorder, anxiety, and addiction. The company has appointed Dr. Riyad Domingo as CEO, who emphasizes inclusivity in drug development. Neurai is set to initiate a capital raise to fund preclinical research and has plans for future shareholder events.

Wuhan General Group, Inc. (WUHN) has announced the rollout of its innovative sustainable packaging solution, Hempcelium™, through its Liviana™ Extra Virgin Olive Oil brand. This unique packaging, made from hemp agri-waste and mushroom mycelium, is designed to significantly reduce environmental impact by being biodegradable and low in carbon footprint. The development of Hempcelium™ is part of M2Bio Sciences’ commitment to sustainability, with plans to license the technology globally. The company anticipates completion of legal processes for the trademark in Q1 2022.

Wuhan General Group, Inc. (WUHN) recently reported an update on its initiatives, highlighting Director Rob Simbowe's visit to Zambia, where he led a Vulnerable Youth Program and contributed to the Fountain of Hope Orphanage. The visit coincided with the inaugural MMA Zambia Symposium attended by MMA Champion Cris Cyborg. Simbowe, a former street child turned MMA champion, is focused on promoting sports nutrition products through M2Bio Sciences. The company aims to advance plant-based cannabinoid and psilocybin research, with an emphasis on developing therapies for addiction and mental health.